Substance Use Prevention and Treatment Initiative

Stimulant use is on the rise across the United States. In 2022, more than 10.2 million people aged 12 and older misused stimulants—a class of drugs that includes cocaine, methamphetamine, and prescription stimulants such as attention-deficit/hyperactivity disorder (ADHD) medications.

Most states collect and report core opioid use disorder (OUD) treatment measures that can improve OUD treatment systems through data-driven decision-making. However, many states have yet to act on this data. A look at how some states have taken the lead on using this data to inform their opioid treatment policies and programs can aid other states in implementing core OUD treatment measures that can help curb the opioid crisis.